[AMN107] New Drug For T315I Mutation Which Causes Gleevec Resistance
1 view
Skip to first unread message
Rob
Jul 27, 2005, 3:00:44 AM7/27/05
to BMS3...@cmlhope.com, C...@cmlhope.com, C...@yahoogroups.com, cml...@googlegroups.com, A group for the AMN107 clinical trial.
New Drug For T315I Mutation Which Causes Gleevec Resistance
Ambit Biosciences has announced the discovery of a new drug that may work
on the T315I
mutation which causes Gleevec resistance in CML patients. This may become another
important new drug in the CML pipeline.
mutation which causes Gleevec resistance in CML patients. This may become another
important new drug in the CML pipeline.
Reply all
Reply to author
Forward
0 new messages